Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Andersen

Showing results (141-150 of 530) with videos related to

Pageof 53
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2015
Determination of the ATP Affinity of the Sarcoplasmic Reticulum Ca(2+)-ATPase by Competitive Inhibition of [γ-(32)P]TNP-8N3-ATP PhotolabelingJohannes D Clausen, David B McIntosh, David G Woolley, et al.
NPJ Vaccines|April 20, 2021
A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovarsAnja Weinreich Olsen, Ida Rosenkrands, Martin J Holland, et al.
Cellular Signalling|August 8, 2007
Mechanisms for oncogenic activation of the epidermal growth factor receptorRoza Zandi, Alice Bjerregaard Larsen, Peter Andersen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 9, 2017
A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522Fabrice Rose, Jeanette Erbo Wern, Francesca Gavins, et al.
Frontiers in Immunology|June 2, 2017
Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted <i>Chlamydia</i> Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital TractJeanette Erbo Wern, Maria Rathmann Sorensen, Anja Weinreich Olsen, et al.
Work (Reading, Mass.)|March 3, 2020
The Demand-Control model and work-related threats and violence: Short- and long-term associationsLars Peter Andersen, Karin Biering, Annie Hogh, et al.
The Journal of Biological Chemistry|September 30, 2005
Functional comparison between secretory pathway Ca2+/Mn2+-ATPase (SPCA) 1 and sarcoplasmic reticulum Ca2+-ATPase (SERCA) 1 isoforms by steady-state and transient kinetic analysesLeonard Dode, Jens Peter Andersen, Luc Raeymaekers, et al.
The Journal of Pharmacy and Pharmacology|June 1, 2006
A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in miceAnil Vangala, Daniel Kirby, Ida Rosenkrands, et al.
European Journal of Immunology|November 17, 2006
Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosisThomas Bennekov, Jes Dietrich, Ida Rosenkrands, et al.
Infection and Immunity|March 11, 2015
Protein energy malnutrition during vaccination has limited influence on vaccine efficacy but abolishes immunity if administered during Mycobacterium tuberculosis infectionTruc Hoang, Else Marie Agger, Joseph P Cassidy, et al.
Pageof 53

Showing results (141-150 of 530) with videos related to

Sort By:
Pageof 53
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2015
Determination of the ATP Affinity of the Sarcoplasmic Reticulum Ca(2+)-ATPase by Competitive Inhibition of [γ-(32)P]TNP-8N3-ATP PhotolabelingJohannes D Clausen, David B McIntosh, David G Woolley, et al.
NPJ Vaccines|April 20, 2021
A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovarsAnja Weinreich Olsen, Ida Rosenkrands, Martin J Holland, et al.
Cellular Signalling|August 8, 2007
Mechanisms for oncogenic activation of the epidermal growth factor receptorRoza Zandi, Alice Bjerregaard Larsen, Peter Andersen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 9, 2017
A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522Fabrice Rose, Jeanette Erbo Wern, Francesca Gavins, et al.
Frontiers in Immunology|June 2, 2017
Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted <i>Chlamydia</i> Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital TractJeanette Erbo Wern, Maria Rathmann Sorensen, Anja Weinreich Olsen, et al.
Work (Reading, Mass.)|March 3, 2020
The Demand-Control model and work-related threats and violence: Short- and long-term associationsLars Peter Andersen, Karin Biering, Annie Hogh, et al.
The Journal of Biological Chemistry|September 30, 2005
Functional comparison between secretory pathway Ca2+/Mn2+-ATPase (SPCA) 1 and sarcoplasmic reticulum Ca2+-ATPase (SERCA) 1 isoforms by steady-state and transient kinetic analysesLeonard Dode, Jens Peter Andersen, Luc Raeymaekers, et al.
The Journal of Pharmacy and Pharmacology|June 1, 2006
A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in miceAnil Vangala, Daniel Kirby, Ida Rosenkrands, et al.
European Journal of Immunology|November 17, 2006
Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosisThomas Bennekov, Jes Dietrich, Ida Rosenkrands, et al.
Infection and Immunity|March 11, 2015
Protein energy malnutrition during vaccination has limited influence on vaccine efficacy but abolishes immunity if administered during Mycobacterium tuberculosis infectionTruc Hoang, Else Marie Agger, Joseph P Cassidy, et al.
Pageof 53